Form 4: Ironwood Pharmaceuticals Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Duane Jon R. Duane recently purchased 6,920 shares of Ironwood Pharmaceuticals (IRWD) at $8.7 per share, increasing his total holdings to 121,028 shares.
Summary
- On March 6, 2024, Duane Jon R., a director at Ironwood Pharmaceuticals, acquired 6,920 shares of Class A Common Stock.
- The purchase price was $8.7 per share.
- Following the transaction, Duane Jon R. directly owns 121,028 shares of Ironwood Pharmaceuticals.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of the transaction: Duane Jon R. acquired 6,920 shares of Ironwood Pharmaceuticals. |
| 03/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.